CATALYSIS Advises Disposable Point-of-Care Diagnostic Developer Molecular Vision Ltd. on Sale of Controlling Equity Stake to Abingdon Health
CATALYSIS CAPITAL PARTNERS is pleased to announce that it acted as the exclusive financial advisor to Molecular Vision Ltd. on the sale of a controlling equity stake to Abingdon Health Ltd. Financial terms were not disclosed. Read more →